Establishment Labs Holdings Inc (ESTA)

Etorro trading 970x250

About Establishment Labs Holdings Inc

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand. It also provides Divina 3D surgical simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica. Address: Building B15 and 25, Alajuela, Costa Rica

Establishment Labs Holdings Inc News and around…

Latest news about Establishment Labs Holdings Inc (ESTA) common stock and company :

Does Establishment Labs Holdings (NASDAQ:ESTA) Have A Healthy Balance Sheet?
11 Aug, 2022 Yahoo! Finance

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates
08 Aug, 2022 Yahoo! Finance

Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of -114.29% and 8.97%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Establishment Labs Reports Record Second Quarter 2022 Financial Results
08 Aug, 2022 FinancialContent

Establishment Labs Holdings Inc. (Nasdaq: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the second quarter ended June 30, 2022.

Earnings Outlook For Establishment Labs Hldgs
05 Aug, 2022 FinancialContent

Establishment Labs Hldgs (NASDAQ:ESTA) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors ...

Implied SMLF Analyst Target Price: $64
03 Aug, 2022 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares MSCI USA Small-Cap Multifactor ETF (SMLF), we found that the implied analyst target price for the ETF based upon its underlying holdings is $63.68 per unit.

Establishment Labs Announces Complete Enrollment in Motiva US IDE Study
03 Aug, 2022 FinancialContent

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it has completed enrollment in the Motiva US IDE clinical study. The final surgery in the primary reconstruction cohort was completed at Northwestern Memorial Hospital. The Augmentation cohort, which finished enrollment in August of 2019, will complete its third year of study follow-up this month.

Establishment Labs to Announce Second Quarter 2022 Financial Results on August 8
25 Jul, 2022 FinancialContent

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended June 30, 2022 after the market closes on Monday, August 8, 2022, and will host a conference call at 4:30 pm ET that day to discuss those results.

Establishment Labs Releases 2021 Sustainability Review
19 Jul, 2022 FinancialContent

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced publication of its 2021 Sustainability Review to coincide with the fourth anniversary of the company’s public listing on NASDAQ.

Analysts Anticipate FPX Will Reach $114
01 Jul, 2022 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust US Equity Opportunities ETF (FPX), we found that the implied analyst target price for the ETF based upon its underlying holdings is $113.86 per unit.

When Will Establishment Labs Holdings Inc. (NASDAQ:ESTA) Become Profitable?
16 Jun, 2022 Yahoo! Finance

Establishment Labs Holdings Inc. ( NASDAQ:ESTA ) is possibly approaching a major achievement in its business, so we...

Establishment Labs to Present at the Jefferies Healthcare Conference
06 Jun, 2022 FinancialContent

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder and Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, will present at the Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 10:30 am Eastern Time.

Analysts See 33% Gains Ahead For The Holdings of SMLF
24 May, 2022 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares MSCI USA Small-Cap Multifactor ETF (SMLF), we found that the implied analyst target price for the ETF based upon its underlying holdings is $66.66 per unit.

Possible turnaround for Establishment Labs Holdings Inc. (NASDAQ:ESTA) insiders, still down US$573k after a US$4.5m shopping spree
24 May, 2022 Yahoo! Finance

Insiders who bought US$4.5m worth of Establishment Labs Holdings Inc. ( NASDAQ:ESTA ) stock in the last year have seen...

Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue Estimates
09 May, 2022 Yahoo! Finance

Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of 42.86% and 8.62%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

RSI Alert: Establishment Labs Holdings (ESTA) Now Oversold
09 May, 2022 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Establishment Labs Reports Record First Quarter 2022 Financial Results
09 May, 2022 FinancialContent

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the first quarter ended March 31, 2022.

Establishment Labs Holdings (ESTA) Shares Cross Below 200 DMA
06 May, 2022 FinancialContent

In trading on Friday, shares of Establishment Labs Holdings Inc (ESTA) crossed below their 200 day moving average of $67.20, changing hands as low as $63.02 per share. Establishment Labs Holdings Inc shares are currently trading down about 5.3% on the day..

A Preview Of Establishment Labs Hldgs's Earnings
06 May, 2022 FinancialContent

Establishment Labs Hldgs (NASDAQ:ESTA) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors ...

What Kind Of Investors Own Most Of Establishment Labs Holdings Inc. (NASDAQ:ESTA)?
01 May, 2022 Yahoo! Finance

If you want to know who really controls Establishment Labs Holdings Inc. ( NASDAQ:ESTA ), then you'll have to look at...

Establishment Labs to Announce First Quarter 2022 Financial Results on May 9
28 Apr, 2022 FinancialContent

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended March 31, 2022 after the market closes on Monday, May 9, 2022, and will host a conference call at 4:30 pm ET that day to discuss those results.

Establishment Labs Enters Into $225 Million Credit Facility With Oaktree
26 Apr, 2022 FinancialContent

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that it has entered into a $225 million term loan financing facility with funds managed by Oaktree Capital Management, L.P. (“Oaktree”).

Establishment Labs Notes Presentation of 2-Year Results from Motiva US IDE Study at The Aesthetic Meeting 2022
21 Apr, 2022 FinancialContent

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today noted the presentation of interim study data from the augmentation cohort of its Motiva US IDE Study. This Study Update includes two-year patient follow-up data for primary augmentation subjects. The Medical Director of the Study, Dr. Caroline Glicksman, who is also a Principal Investigator in the Study, is presenting the results today at The Aesthetic Meeting 2022 in San Diego, California.

Establishment Labs Stock Clears Technical Benchmark, Hitting 90-Plus RS Rating
20 Apr, 2022 FinancialContent

A Relative Strength Rating upgrade for Establishment Labs shows improving technical performance.

Executives Buy More Than $32M Of 4 Stocks
18 Apr, 2022 FinancialContent

Although U.S. stock futures traded lower this morning on Monday, there were a few notable insider trades. When insiders purchase ...

Establishment Labs Announces Participation in The Aesthetic Meeting 2022 and Sessions of Interest
11 Apr, 2022 FinancialContent

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its participation in The Aesthetic Meeting 2022, which is being held April 20-24 in San Diego, California, as well as sessions of interest at the meeting.

ESTA Crosses Above Key Moving Average Level
29 Mar, 2022 FinancialContent

In trading on Tuesday, shares of Establishment Labs Holdings Inc (ESTA) crossed above their 200 day moving average of $68.37, changing hands as high as $71.61 per share. Establishment Labs Holdings Inc shares are currently trading up about 5.3% on the day..

The 19% return this week takes Establishment Labs Holdings' (NASDAQ:ESTA) shareholders three-year gains to 138%
22 Mar, 2022 Yahoo! Finance

It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...

Establishment Labs Hldgs's Return On Capital Employed Insights
08 Mar, 2022 FinancialContent

According to data from Benzinga Pro, during Q4, Establishment Labs Hldgs's (NASDAQ:ESTA) reported sales totaled $35.31 million. Despite ...

Establishment Labs to Present at the Cowen 42nd Annual Health Care Conference
02 Mar, 2022 FinancialContent

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder and Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, will present virtually at the Cowen 42nd Annual Health Care Conference on Monday, March 7, 2022 at 2:10 pm Eastern Time.

Recap: Establishment Labs Hldgs Q4 Earnings
01 Mar, 2022 FinancialContent

Establishment Labs Hldgs (NASDAQ:ESTA) reported its Q4 earnings results on Tuesday, March 1, 2022 at 08:00 AM. Here's ...

Establishment Labs Holdings Inc (ESTA) is a NASDAQ Common Stock listed in , ,

970x250